United States Intranasal Corticosteroids Market Report 2016

November 2016 | 103 pages | ID: U317EA94202EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Intranasal Corticosteroids

Revenue, means the sales value of Intranasal Corticosteroids

This report studies sales (consumption) of Intranasal Corticosteroids in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GSK
• Merck
• Sanofi
• Johnson & Johnson
• ALK-Abello
• UCB
• Kyowo Hako Kirin
• Stallergenes Greer

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Intranasal Corticosteroids in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Intranasal Corticosteroids Market Report 2016

1 INTRANASAL CORTICOSTEROIDS OVERVIEW

1.1 Product Overview and Scope of Intranasal Corticosteroids
1.2 Classification of Intranasal Corticosteroids
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Intranasal Corticosteroids
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Intranasal Corticosteroids (2011-2021)
  1.4.1 United States Intranasal Corticosteroids Sales and Growth Rate (2011-2021)
  1.4.2 United States Intranasal Corticosteroids Revenue and Growth Rate (2011-2021)

2 UNITED STATES INTRANASAL CORTICOSTEROIDS COMPETITION BY MANUFACTURERS

2.1 United States Intranasal Corticosteroids Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Intranasal Corticosteroids Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Intranasal Corticosteroids Average Price by Manufactures (2015 and 2016)
2.4 Intranasal Corticosteroids Market Competitive Situation and Trends
  2.4.1 Intranasal Corticosteroids Market Concentration Rate
  2.4.2 Intranasal Corticosteroids Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES INTRANASAL CORTICOSTEROIDS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Intranasal Corticosteroids Sales and Market Share by Type (2011-2016)
3.2 United States Intranasal Corticosteroids Revenue and Market Share by Type (2011-2016)
3.3 United States Intranasal Corticosteroids Price by Type (2011-2016)
3.4 United States Intranasal Corticosteroids Sales Growth Rate by Type (2011-2016)

4 UNITED STATES INTRANASAL CORTICOSTEROIDS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Intranasal Corticosteroids Sales and Market Share by Application (2011-2016)
4.2 United States Intranasal Corticosteroids Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES INTRANASAL CORTICOSTEROIDS MANUFACTURERS PROFILES/ANALYSIS

5.1 GSK
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GSK Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi
  5.3.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Johnson & Johnson
  5.4.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Johnson & Johnson Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 ALK-Abello
  5.5.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 ALK-Abello Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 UCB
  5.6.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 UCB Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Kyowo Hako Kirin
  5.7.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Kyowo Hako Kirin Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Stallergenes Greer
  5.8.2 Intranasal Corticosteroids Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Stallergenes Greer Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 INTRANASAL CORTICOSTEROIDS MANUFACTURING COST ANALYSIS

6.1 Intranasal Corticosteroids Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Intranasal Corticosteroids

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Intranasal Corticosteroids Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Intranasal Corticosteroids Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES INTRANASAL CORTICOSTEROIDS MARKET FORECAST (2016-2021)

10.1 United States Intranasal Corticosteroids Sales, Revenue Forecast (2016-2021)
10.2 United States Intranasal Corticosteroids Sales Forecast by Type (2016-2021)
10.3 United States Intranasal Corticosteroids Sales Forecast by Application (2016-2021)
10.4 Intranasal Corticosteroids Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intranasal Corticosteroids
Table Classification of Intranasal Corticosteroids
Figure United States Sales Market Share of Intranasal Corticosteroids by Type in 2015
Table Application of Intranasal Corticosteroids
Figure United States Sales Market Share of Intranasal Corticosteroids by Application in 2015
Figure United States Intranasal Corticosteroids Sales and Growth Rate (2011-2021)
Figure United States Intranasal Corticosteroids Revenue and Growth Rate (2011-2021)
Table United States Intranasal Corticosteroids Sales of Key Manufacturers (2015 and 2016)
Table United States Intranasal Corticosteroids Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Intranasal Corticosteroids Sales Share by Manufacturers
Figure 2016 Intranasal Corticosteroids Sales Share by Manufacturers
Table United States Intranasal Corticosteroids Revenue by Manufacturers (2015 and 2016)
Table United States Intranasal Corticosteroids Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Intranasal Corticosteroids Revenue Share by Manufacturers
Table 2016 United States Intranasal Corticosteroids Revenue Share by Manufacturers
Table United States Market Intranasal Corticosteroids Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Intranasal Corticosteroids Average Price of Key Manufacturers in 2015
Figure Intranasal Corticosteroids Market Share of Top 3 Manufacturers
Figure Intranasal Corticosteroids Market Share of Top 5 Manufacturers
Table United States Intranasal Corticosteroids Sales by Type (2011-2016)
Table United States Intranasal Corticosteroids Sales Share by Type (2011-2016)
Figure United States Intranasal Corticosteroids Sales Market Share by Type in 2015
Table United States Intranasal Corticosteroids Revenue and Market Share by Type (2011-2016)
Table United States Intranasal Corticosteroids Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Intranasal Corticosteroids by Type (2011-2016)
Table United States Intranasal Corticosteroids Price by Type (2011-2016)
Figure United States Intranasal Corticosteroids Sales Growth Rate by Type (2011-2016)
Table United States Intranasal Corticosteroids Sales by Application (2011-2016)
Table United States Intranasal Corticosteroids Sales Market Share by Application (2011-2016)
Figure United States Intranasal Corticosteroids Sales Market Share by Application in 2015
Table United States Intranasal Corticosteroids Sales Growth Rate by Application (2011-2016)
Figure United States Intranasal Corticosteroids Sales Growth Rate by Application (2011-2016)
Table GSK Basic Information List
Table GSK Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Intranasal Corticosteroids Sales Market Share (2011-2016)
Table ALK-Abello Basic Information List
Table ALK-Abello Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALK-Abello Intranasal Corticosteroids Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Kyowo Hako Kirin Basic Information List
Table Kyowo Hako Kirin Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowo Hako Kirin Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Stallergenes Greer Basic Information List
Table Stallergenes Greer Intranasal Corticosteroids Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stallergenes Greer Intranasal Corticosteroids Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intranasal Corticosteroids
Figure Manufacturing Process Analysis of Intranasal Corticosteroids
Figure Intranasal Corticosteroids Industrial Chain Analysis
Table Raw Materials Sources of Intranasal Corticosteroids Major Manufacturers in 2015
Table Major Buyers of Intranasal Corticosteroids
Table Distributors/Traders List
Figure United States Intranasal Corticosteroids Production and Growth Rate Forecast (2016-2021)
Figure United States Intranasal Corticosteroids Revenue and Growth Rate Forecast (2016-2021)
Table United States Intranasal Corticosteroids Production Forecast by Type (2016-2021)
Table United States Intranasal Corticosteroids Consumption Forecast by Application (2016-2021)